Patrick Mahaffy

With a rich background in biotechnology, Patrick Mahaffy's journey began when he took the CEO position at Clovis Oncology, an establishment he birthed in 2009. Leading from the front, Clovis set benchmarks by introducing drugs to combat ovarian and prostate cancer for American and European markets. A novel endeavor under his guidance saw Clovis initiating preliminary clinical studies on targeted radionuclide therapies - a cutting-edge dimension in oncology drug research. Sadly, by the end of 2022, Clovis met its end, cornered by COVID-19's devastating effects on cancer detection and FDA's apprehensions concerning a particular drug class for ovarian cancer.

But his narrative isn't just about Clovis. Preceding this venture, between 2000-2008, he was the torchbearer for Pharmion until its merger with Celgene, currently under Bristol Myers Squibb. From 1992-1998, he piloted Nexstar Pharmaceuticals until its acquisition by Gilead Sciences. Both enterprises under him played pivotal roles in introducing breakthrough oncology treatments in Europe and the US.

A striking feature of his leadership remains the enduring legacy of the drugs he championed. These drugs, today, are the pillars of treatment for specific ailments they were designed to address.

Delving into his initial days, he carved his niche as an investment banker at Warburg Pincus from 1986-1992. Parallelly, his academic pursuit saw him garnering a Master's in International Affairs from Columbia University in 1986, closely following his Bachelor's from Lewis and Clark College.

Though reticent about his charity ventures, whispers in corridors acclaim him for his generous heart. His allegiance leans towards funds dedicated to families in distress. Further cementing his connection with Lewis & Clark College, he serves diligently on its Board of Trustees.

His professional brilliance stems from his visionary foresight, immersive leadership, relentless knowledge quest, and mastery over drug evolution. His pride swells in setting up commercial institutions in the US and Europe and the sustained impact of the drugs he endorsed.

On a personal note, Patrick Mahaffy harbors an enthusiasm for sports, especially hiking and golf, complemented by his love for literature. A serendipitous discovery in 2009 - ancient Clovis tools in his backyard, ignited his curiosity in archaeology. These relics, dubbed the "he Cache," now adorns the University of Colorado History Museum. While the limelight often graces his professional strides, he cherishes intimate moments, veiled from the public eye, alongside family and confidants.